We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
(-2.8%)
Cap. Flow
-$952M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 2 |
Prologis
PLD
|
+$150M |
| 3 |
Chevron
CVX
|
+$109M |
| 4 |
Qualcomm
QCOM
|
+$101M |
| 5 |
Paycom
PAYC
|
+$90.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
+$230M |
| 2 |
Kimberly-Clark
KMB
|
+$160M |
| 3 |
Stanley Black & Decker
SWK
|
+$130M |
| 4 |
Paychex
PAYX
|
+$113M |
| 5 |
Dominion Energy
D
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.81% |
| 2 | Healthcare | 17.11% |
| 3 | Financials | 12.73% |
| 4 | Industrials | 9.87% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMK
1676
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $30.3K | ﹤0.01% |
876
-13,735
| -94% | -$473K |
|
1677
Alerus Financial
ALRS
$832M
| $29.8K | ﹤0.01% |
1,519
+1,203
| +381% | +$23.7K |
|
1678
Green Brick Partners
GRBK
$2.89B
| $29.2K | ﹤0.01% |
510
-42
| -8% | -$2.35K |
|
1679
Sterling Infrastructure
STRL
$14B
| $29K | ﹤0.01% |
245
-9
| -4% | -$1.03K |
|
1680
Insight Enterprises
NSIT
$4.72B
| $29K | ﹤0.01% |
146
-11
| -7% | -$2.14K |
|
1681
Greif Class B
GEF.B
$4B
| $28.8K | ﹤0.01% |
461
-20
| -4% | -$1.29K |
|
1682
Allogene Therapeutics
ALLO
$594M
| $28.7K | ﹤0.01% |
+12,300
| New | +$36.3K |
|
|
OLO
1683
DELISTED
Olo Inc
OLO
| $28.5K | ﹤0.01% |
6,443
+6,442
| +644,200% | +$30.5K |
|
1684
Mueller Industries
MLI
$13.4B
| $28.3K | ﹤0.01% |
+994
| New | +$27.8K |
|
1685
Universal Logistics Holdings
ULH
$497M
| $28.3K | ﹤0.01% |
697
-26,636
| -97% | -$1.08M |
|
1686
Hasbro
HAS
$12.7B
| $27.1K | ﹤0.01% |
464
-11
| -2% | -$653 |
|
1687
C.H. Robinson
CHRW
$18.4B
| $26.9K | ﹤0.01% |
305
-2,844
| -90% | -$227K |
|
1688
Quad
QUAD
$492M
| $26.9K | ﹤0.01% |
4,927
+685
| +16% | +$3.37K |
|
|
ITOS
1689
DELISTED
iTeos Therapeutics
ITOS
| $26.8K | ﹤0.01% |
1,805
-885
| -33% | -$12.7K |
|
1690
Nordic American Tanker
NAT
$1.66B
| $26.7K | ﹤0.01% |
6,697
+82
| +1% | +$330 |
|
1691
Central Garden & Pet Co Class A
CENTA
$2.17B
| $26.4K | ﹤0.01% |
+800
| New | +$28.8K |
|
1692
Hanmi Financial
HAFC
$954M
| $25.9K | ﹤0.01% |
1,550
-12
| -0.8% | -$187 |
|
|
CLDT
1693
Chatham Lodging
CLDT
$608M
| $25.8K | ﹤0.01% |
3,023
+9
| +0.3% | +$81 |
|
1694
Dave & Buster's
PLAY
$239M
| $25.5K | ﹤0.01% |
640
+69
| +12% | +$3.58K |
|
|
BRY
1695
DELISTED
Berry Corp
BRY
| $25.2K | ﹤0.01% |
+3,907
| New | +$29.1K |
|
1696
Alpha Metallurgical Resources
AMR
$2.39B
| $24.7K | ﹤0.01% |
+88
| New | +$27.2K |
|
1697
Herc Holdings
HRI
$4.65B
| $24.5K | ﹤0.01% |
184
+12
| +7% | +$1.77K |
|
1698
UFP Technologies
UFPT
$2.13B
| $24.3K | ﹤0.01% |
92
-6
| -6% | -$1.48K |
|
1699
AMERISAFE
AMSF
$460M
| $24.2K | ﹤0.01% |
552
-527
| -49% | -$24.2K |
|
|
BIG
1700
DELISTED
Big Lots, Inc.
BIG
| $24.2K | ﹤0.01% |
13,997
-547,766
| -98% | -$1.77M |
|
Similar funds
Federated Hermes's Q2 2024 Portfolio in Review
As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
- Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
- Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
- Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
- Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
- Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
- Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.
Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.